Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50357891 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_787640 (CHEMBL1918093) | ||
IC50 | 141±n/a nM | ||
Citation | Lumeras, W; Vidal, L; Vidal, B; Balagué, C; Orellana, A; Maldonado, M; Domínguez, M; Segarra, V; Caturla, F 1,7-Naphthyridine 1-oxides as novel potent and selective inhibitors of p38 mitogen activated protein kinase. J Med Chem54:7899-910 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50357891 | |||
n/a | |||
Name | BDBM50357891 | ||
Synonyms: | CHEMBL1916348 | ||
Type | Small organic molecule | ||
Emp. Form. | C22H16F2N2O3 | ||
Mol. Mass. | 394.3708 | ||
SMILES | COc1cccc(OC)c1-c1[n+]([O-])ccc2c(ccnc12)-c1ccc(F)cc1F |(-10.9,-39.4,;-9.56,-38.63,;-8.23,-39.39,;-8.23,-40.93,;-6.89,-41.7,;-5.55,-40.92,;-5.56,-39.38,;-4.23,-38.61,;-2.9,-39.37,;-6.89,-38.62,;-6.9,-37.09,;-8.23,-36.32,;-9.57,-37.09,;-8.23,-34.77,;-6.9,-34,;-5.57,-34.77,;-4.23,-33.99,;-2.9,-34.77,;-2.9,-36.32,;-4.24,-37.08,;-5.57,-36.31,;-4.23,-32.46,;-5.56,-31.7,;-5.57,-30.16,;-4.23,-29.38,;-4.23,-27.84,;-2.9,-30.15,;-2.9,-31.69,;-1.56,-32.46,)| | ||
Structure |